dalteparin has been researched along with Bed Sores in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pannucci, CJ | 1 |
Wachtman, CF | 1 |
Dreszer, G | 1 |
Bailey, SH | 1 |
Portschy, PR | 1 |
Hamill, JB | 1 |
Hume, KM | 1 |
Hoxworth, RE | 1 |
Kalliainen, LK | 1 |
Rubin, JP | 1 |
Pusic, AL | 1 |
Wilkins, EG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial[NCT02615366] | Phase 4 | 800 participants (Anticipated) | Interventional | 2016-02-29 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for dalteparin and Bed Sores
Article | Year |
---|---|
The effect of postoperative enoxaparin on risk for reoperative hematoma.
Topics: Anticoagulants; Bariatric Surgery; Benchmarking; Clinical Protocols; Enoxaparin; Hematoma; Humans; M | 2012 |